PRECISIONGATE
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Nov 2024)
What this means for you
This application is over — abandoned 18 Nov 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90479940
- Mark type
- Stylized text
- Filed
- 21 Jan 2021
- Published for opposition
- 17 Aug 2021
- Abandoned
- 18 Nov 2024
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy platforms for manufacturing cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes
Owner
- Revitope Oncology, Inc., Cambridge, MA, US
- Revitope Oncology, Inc., Cambridge, MA, US
Prosecution history
- 18 Nov 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Nov 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Apr 2024 — SOU EXTENSION 5 GRANTED
- 12 Apr 2024 — SOU EXTENSION 5 FILED
- 12 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Oct 2023 — SOU EXTENSION 4 GRANTED
- 10 Oct 2023 — SOU EXTENSION 4 FILED
- 10 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 13 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Apr 2023 — SOU EXTENSION 3 GRANTED
- 11 Apr 2023 — SOU EXTENSION 3 FILED
- 11 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 14 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED